Written by Klarity Editorial Team
Published: Aug 21, 2026

Last updated: August 21, 2026
Fanapt (iloperidone) is a second-generation (atypical) antipsychotic used for schizophrenia in adults and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. It is taken by mouth twice daily, usually with a slow titration to reduce dizziness from blood-pressure drops when standing. This guide covers how iloperidone works, label dosing ranges, side effects and the boxed dementia warning, QT and drug-interaction cautions, and when online psychiatry may be enough for evaluation and follow-up.
See if online depression or mood care may be a fit →
Browse Klarity condition pages →
Iloperidone is an atypical antipsychotic. According to MedlinePlus (last revised 12/15/2025), it is used to treat symptoms of schizophrenia and bipolar I disorder. It works by changing the activity of certain natural substances in the brain.
NAMI describes iloperidone as a second-generation antipsychotic (SGA) that rebalances dopamine and serotonin to improve thinking, mood, and behavior. Brand name: Fanapt®. Oral tablet strengths commonly listed by NAMI: 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, and 12 mg.
Generic availability and formulary preference vary by plan and pharmacy. Whether brand or generic is preferred is a coverage decision, not something Klarity can promise in advance.
Iloperidone is discussed clinically as blocking dopamine D2 and serotonin 5-HT2A receptors (among other receptor effects). That profile can reduce hallucinations, delusions, and disorganized thinking in schizophrenia, and the FDA label also supports acute manic or mixed bipolar I episodes in adults. It still carries the class warnings of atypical antipsychotics and needs medical supervision.
MedlinePlus notes that iloperidone may help control symptoms but does not cure the condition. Continue the medicine even when you feel well unless your prescriber changes the plan. Do not stop suddenly without guidance.
NAMI’s timing summary:
MedlinePlus also notes it may take up to 2 weeks or longer before symptoms begin to improve for some people.
Per the DailyMed FANAPT (iloperidone) prescribing information (label updated May 6, 2026; revised 5/2026), Fanapt is an atypical antipsychotic indicated for:
Your clinician matches the indication, dose, monitoring plan, and any need for in-person labs or ECG to your history. Off-label uses exist in practice; those decisions belong in a documented clinical relationship. NAMI notes that off-label use requires clear justification and discussion of evidence limits.
Always follow the dose on your prescription. DailyMed highlights state Fanapt is administered orally twice daily without regard to meals, and the dose must be titrated to avoid orthostatic hypotension.
Recommended dosage from the label highlights:
NAMI states the dose usually ranges from about 12 to 24 mg per day total (split BID), started low and increased slowly.
DailyMed describes example titration paths (Titration Pack patterns):
Your exact schedule may differ. What matters is that titration is intentional and supervised.
Other label dosing rules that matter day to day:
Tablet strengths on the label: 1, 2, 4, 6, 8, 10, and 12 mg.
From MedlinePlus and DailyMed:
MedlinePlus advises talking with your clinician about grapefruit and grapefruit juice while on this medicine.
Boxed warning (dementia-related psychosis): Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Fanapt is not approved for dementia-related psychosis. Older adults with dementia may also have a greater chance of stroke or mini-stroke during antipsychotic treatment (MedlinePlus; DailyMed).
Commonly observed adverse reactions on the label (incidence ≥5% and about 2-fold greater than placebo):
MedlinePlus also lists weight gain, nausea, diarrhea, stomach pain, sleepiness, breast enlargement or discharge, missed periods, decreased sexual ability in men, joint pain, and balance trouble among effects that may occur.
Serious risks to know and report promptly (label and MedlinePlus/NAMI summaries):
This is education, not a complete MedGuide. Read the Medication Guide that comes with your prescription and ask your clinician about your personal risk factors.
DailyMed: reduce Fanapt dose when co-administered with a strong CYP2D6 or strong CYP3A4 inhibitor.
NAMI examples of medicines that may raise iloperidone levels or effects include clarithromycin, fluoxetine, ketoconazole, and paroxetine. Carbamazepine may lower levels. NAMI also flags additive QT risk with certain other antipsychotics (for example chlorpromazine, thioridazine, asenapine, paliperidone, quetiapine, ziprasidone) and some antiarrhythmics (procainamide, quinidine, amiodarone, dronedarone, sotalol). Blood-pressure medicines may worsen hypotension. Parkinson’s disease dopamine agonists may be opposed by antipsychotics.
Share a full medication and supplement list, including alcohol use, before dose changes. Alcohol can worsen side effects (MedlinePlus).
Third-trimester antipsychotic exposure may cause extrapyramidal and/or withdrawal symptoms in newborns (DailyMed; NAMI). Discuss pregnancy plans before conception when possible. DailyMed advises not to breastfeed while using Fanapt; NAMI notes limited human milk data and animal excretion findings. Severe hepatic impairment: not recommended. CYP2D6 poor metabolizer status and inhibitor drugs change dose targets.
Iloperidone is one option among many SGAs. Related Klarity education pages:
Choice depends on diagnosis, prior response, metabolic and cardiac risk, drug interactions, titration tolerance, cost, and preference. No blog post can rank one medicine as “best” for every person.
Many adults use telehealth for psychiatric evaluation, medication management, and follow-up when the clinical picture is stable enough for remote care. Klarity connects patients with licensed providers in a network of 2,000+ clinicians. Online visits can cover history, symptom review, medication counseling, and refill or adjustment decisions within scope and state rules.
In-person or higher-acuity care is more appropriate when there is active suicidal intent with plan and means, severe agitation or inability to engage safely by video, suspected NMS, new severe movement disorders, unexplained fever with rigidity, suspected cardiac arrhythmia symptoms (syncope, severe palpitations) that need urgent evaluation, or when your clinician requires labs, ECG, or depot injections that cannot be completed remotely.
If you are in crisis, call or text 988 (U.S. Suicide & Crisis Lifeline), call 911, or go to the nearest emergency department.
Check whether online mood or psychiatric care may fit your situation →
Coverage for Fanapt or generic iloperidone may vary by plan, formulary tier, prior authorization rules, and pharmacy benefit design. Some plans prefer other atypical antipsychotics first. Klarity cannot guarantee that any specific plan will cover iloperidone. Verify benefits with your insurer and pharmacy before you rely on a particular brand or copay.
Disclaimer: This article is for educational purposes only and is not medical advice, a diagnosis, or a treatment plan. Medication decisions require a licensed clinician who knows your history. Insurance coverage varies by plan; confirm benefits before booking or filling a prescription. Klarity does not guarantee coverage, specific medications, or clinical outcomes.
Explore Klarity condition resources →
Find the right provider for your needs — select your state to find expert care near you.